Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

NCT00751348 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00751348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00751348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2008
Completion date
May 27, 2010
Enrollment
475 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

measles, mumps, rubella, varicella